Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.

Identifieur interne : 003775 ( Main/Exploration ); précédent : 003774; suivant : 003776

Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.

Auteurs : L. Lacroix [États-Unis] ; J. Lacoste ; J F Reddoch ; J L Mergny ; D D Levy ; M M Seidman ; M D Matteucci ; P M Glazer

Source :

RBID : pubmed:10026270

Descripteurs français

English descriptors

Abstract

Oligonucleotides capable of sequence-specific triple helix formation have been proposed as DNA binding ligands useful for modulation of gene expression and for directed genome modification. However, the effectiveness of such triplex-forming oligonucleotides (TFOs) depends on their ability to bind to their target sites within cells, and this can be limited under physiologic conditions. In particular, triplex formation in the pyrimidine motif is favored by unphysiologically low pH and high magnesium concentrations. To address these limitations, a series of pyrimidine TFOs were tested for third-strand binding under a variety of conditions. Those containing 5-(1-propynyl)-2'-deoxyuridine (pdU) and 5-methyl-2'-deoxycytidine (5meC) showed superior binding characteristics at neutral pH and at low magnesium concentrations, as determined by gel mobility shift assays and thermal dissociation profiles. Over a range of Mg2+ concentrations, pdU-modified TFOs formed more stable triplexes than did TFOs containing 2'-deoxythymidine. At 1 mM Mg2+, a DeltaTm of 30 degreesC was observed for pdU- versus T-containing 15-mers (of generic sequence 5' TTTTCTTTTTTCTTTTCT 3') binding to the cognate A:T bp rich site, indicating that pdU-containing TFOs are capable of substantial binding even at physiologically low Mg2+ concentrations. In addition, the pdU-containing TFOs were superior in gene targeting experiments in mammalian cells, yielding 4-fold higher mutation frequencies in a shuttle vector-based mutagenesis assay designed to detect mutations induced by third-strand-directed psoralen adducts. These results suggest the utility of the pdU substitution in the pyrimidine motif for triplex-based gene targeting experiments.

DOI: 10.1021/bi982290q
PubMed: 10026270


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.</title>
<author>
<name sortKey="Lacroix, L" sort="Lacroix, L" uniqKey="Lacroix L" first="L" last="Lacroix">L. Lacroix</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Therapeutic Radiology and Genetics, Yale University, New Haven, Connecticut 06536, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Therapeutic Radiology and Genetics, Yale University, New Haven, Connecticut 06536</wicri:regionArea>
<wicri:noRegion>Connecticut 06536</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lacoste, J" sort="Lacoste, J" uniqKey="Lacoste J" first="J" last="Lacoste">J. Lacoste</name>
</author>
<author>
<name sortKey="Reddoch, J F" sort="Reddoch, J F" uniqKey="Reddoch J" first="J F" last="Reddoch">J F Reddoch</name>
</author>
<author>
<name sortKey="Mergny, J L" sort="Mergny, J L" uniqKey="Mergny J" first="J L" last="Mergny">J L Mergny</name>
</author>
<author>
<name sortKey="Levy, D D" sort="Levy, D D" uniqKey="Levy D" first="D D" last="Levy">D D Levy</name>
</author>
<author>
<name sortKey="Seidman, M M" sort="Seidman, M M" uniqKey="Seidman M" first="M M" last="Seidman">M M Seidman</name>
</author>
<author>
<name sortKey="Matteucci, M D" sort="Matteucci, M D" uniqKey="Matteucci M" first="M D" last="Matteucci">M D Matteucci</name>
</author>
<author>
<name sortKey="Glazer, P M" sort="Glazer, P M" uniqKey="Glazer P" first="P M" last="Glazer">P M Glazer</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1999">1999</date>
<idno type="RBID">pubmed:10026270</idno>
<idno type="pmid">10026270</idno>
<idno type="doi">10.1021/bi982290q</idno>
<idno type="wicri:Area/PubMed/Corpus">002647</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002647</idno>
<idno type="wicri:Area/PubMed/Curation">002647</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002647</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002460</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002460</idno>
<idno type="wicri:Area/Ncbi/Merge">000001</idno>
<idno type="wicri:Area/Ncbi/Curation">000001</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000001</idno>
<idno type="wicri:doubleKey">0006-2960:1999:Lacroix L:triplex:formation:by</idno>
<idno type="wicri:Area/Main/Merge">003819</idno>
<idno type="wicri:Area/Main/Curation">003775</idno>
<idno type="wicri:Area/Main/Exploration">003775</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.</title>
<author>
<name sortKey="Lacroix, L" sort="Lacroix, L" uniqKey="Lacroix L" first="L" last="Lacroix">L. Lacroix</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Therapeutic Radiology and Genetics, Yale University, New Haven, Connecticut 06536, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Therapeutic Radiology and Genetics, Yale University, New Haven, Connecticut 06536</wicri:regionArea>
<wicri:noRegion>Connecticut 06536</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lacoste, J" sort="Lacoste, J" uniqKey="Lacoste J" first="J" last="Lacoste">J. Lacoste</name>
</author>
<author>
<name sortKey="Reddoch, J F" sort="Reddoch, J F" uniqKey="Reddoch J" first="J F" last="Reddoch">J F Reddoch</name>
</author>
<author>
<name sortKey="Mergny, J L" sort="Mergny, J L" uniqKey="Mergny J" first="J L" last="Mergny">J L Mergny</name>
</author>
<author>
<name sortKey="Levy, D D" sort="Levy, D D" uniqKey="Levy D" first="D D" last="Levy">D D Levy</name>
</author>
<author>
<name sortKey="Seidman, M M" sort="Seidman, M M" uniqKey="Seidman M" first="M M" last="Seidman">M M Seidman</name>
</author>
<author>
<name sortKey="Matteucci, M D" sort="Matteucci, M D" uniqKey="Matteucci M" first="M D" last="Matteucci">M D Matteucci</name>
</author>
<author>
<name sortKey="Glazer, P M" sort="Glazer, P M" uniqKey="Glazer P" first="P M" last="Glazer">P M Glazer</name>
</author>
</analytic>
<series>
<title level="j">Biochemistry</title>
<idno type="ISSN">0006-2960</idno>
<imprint>
<date when="1999" type="published">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Base Sequence</term>
<term>Binding Sites</term>
<term>COS Cells</term>
<term>DNA (chemistry)</term>
<term>DNA (genetics)</term>
<term>DNA (metabolism)</term>
<term>Deoxyuridine (analogs & derivatives)</term>
<term>Deoxyuridine (chemistry)</term>
<term>Deoxyuridine (metabolism)</term>
<term>Gene Targeting</term>
<term>Genes, Reporter</term>
<term>Genes, Suppressor</term>
<term>Genetic Vectors</term>
<term>Intracellular Fluid (metabolism)</term>
<term>Magnesium (metabolism)</term>
<term>Molecular Sequence Data</term>
<term>Mutagenesis, Site-Directed</term>
<term>Nucleic Acid Denaturation</term>
<term>Oligonucleotides (chemistry)</term>
<term>Oligonucleotides (genetics)</term>
<term>Oligonucleotides (metabolism)</term>
<term>RNA, Transfer (genetics)</term>
<term>Simian virus 40 (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ADN ()</term>
<term>ADN (génétique)</term>
<term>ADN (métabolisme)</term>
<term>ARN de transfert (génétique)</term>
<term>Animaux</term>
<term>Cellules COS</term>
<term>Ciblage de gène</term>
<term>Données de séquences moléculaires</term>
<term>Dénaturation d'acide nucléique</term>
<term>Désoxyuridine ()</term>
<term>Désoxyuridine (analogues et dérivés)</term>
<term>Désoxyuridine (métabolisme)</term>
<term>Gènes rapporteurs</term>
<term>Gènes suppresseurs</term>
<term>Liquide intracellulaire (métabolisme)</term>
<term>Magnésium (métabolisme)</term>
<term>Mutagenèse dirigée</term>
<term>Oligonucléotides ()</term>
<term>Oligonucléotides (génétique)</term>
<term>Oligonucléotides (métabolisme)</term>
<term>Sites de fixation</term>
<term>Séquence nucléotidique</term>
<term>Vecteurs génétiques</term>
<term>Virus simien 40 (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Deoxyuridine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>DNA</term>
<term>Deoxyuridine</term>
<term>Oligonucleotides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>DNA</term>
<term>Oligonucleotides</term>
<term>RNA, Transfer</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>DNA</term>
<term>Deoxyuridine</term>
<term>Magnesium</term>
<term>Oligonucleotides</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>Désoxyuridine</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Simian virus 40</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>ADN</term>
<term>ARN de transfert</term>
<term>Oligonucléotides</term>
<term>Virus simien 40</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Intracellular Fluid</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>ADN</term>
<term>Désoxyuridine</term>
<term>Liquide intracellulaire</term>
<term>Magnésium</term>
<term>Oligonucléotides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Base Sequence</term>
<term>Binding Sites</term>
<term>COS Cells</term>
<term>Gene Targeting</term>
<term>Genes, Reporter</term>
<term>Genes, Suppressor</term>
<term>Genetic Vectors</term>
<term>Molecular Sequence Data</term>
<term>Mutagenesis, Site-Directed</term>
<term>Nucleic Acid Denaturation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>ADN</term>
<term>Animaux</term>
<term>Cellules COS</term>
<term>Ciblage de gène</term>
<term>Données de séquences moléculaires</term>
<term>Dénaturation d'acide nucléique</term>
<term>Désoxyuridine</term>
<term>Gènes rapporteurs</term>
<term>Gènes suppresseurs</term>
<term>Mutagenèse dirigée</term>
<term>Oligonucléotides</term>
<term>Sites de fixation</term>
<term>Séquence nucléotidique</term>
<term>Vecteurs génétiques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Oligonucleotides capable of sequence-specific triple helix formation have been proposed as DNA binding ligands useful for modulation of gene expression and for directed genome modification. However, the effectiveness of such triplex-forming oligonucleotides (TFOs) depends on their ability to bind to their target sites within cells, and this can be limited under physiologic conditions. In particular, triplex formation in the pyrimidine motif is favored by unphysiologically low pH and high magnesium concentrations. To address these limitations, a series of pyrimidine TFOs were tested for third-strand binding under a variety of conditions. Those containing 5-(1-propynyl)-2'-deoxyuridine (pdU) and 5-methyl-2'-deoxycytidine (5meC) showed superior binding characteristics at neutral pH and at low magnesium concentrations, as determined by gel mobility shift assays and thermal dissociation profiles. Over a range of Mg2+ concentrations, pdU-modified TFOs formed more stable triplexes than did TFOs containing 2'-deoxythymidine. At 1 mM Mg2+, a DeltaTm of 30 degreesC was observed for pdU- versus T-containing 15-mers (of generic sequence 5' TTTTCTTTTTTCTTTTCT 3') binding to the cognate A:T bp rich site, indicating that pdU-containing TFOs are capable of substantial binding even at physiologically low Mg2+ concentrations. In addition, the pdU-containing TFOs were superior in gene targeting experiments in mammalian cells, yielding 4-fold higher mutation frequencies in a shuttle vector-based mutagenesis assay designed to detect mutations induced by third-strand-directed psoralen adducts. These results suggest the utility of the pdU substitution in the pyrimidine motif for triplex-based gene targeting experiments.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Glazer, P M" sort="Glazer, P M" uniqKey="Glazer P" first="P M" last="Glazer">P M Glazer</name>
<name sortKey="Lacoste, J" sort="Lacoste, J" uniqKey="Lacoste J" first="J" last="Lacoste">J. Lacoste</name>
<name sortKey="Levy, D D" sort="Levy, D D" uniqKey="Levy D" first="D D" last="Levy">D D Levy</name>
<name sortKey="Matteucci, M D" sort="Matteucci, M D" uniqKey="Matteucci M" first="M D" last="Matteucci">M D Matteucci</name>
<name sortKey="Mergny, J L" sort="Mergny, J L" uniqKey="Mergny J" first="J L" last="Mergny">J L Mergny</name>
<name sortKey="Reddoch, J F" sort="Reddoch, J F" uniqKey="Reddoch J" first="J F" last="Reddoch">J F Reddoch</name>
<name sortKey="Seidman, M M" sort="Seidman, M M" uniqKey="Seidman M" first="M M" last="Seidman">M M Seidman</name>
</noCountry>
<country name="États-Unis">
<noRegion>
<name sortKey="Lacroix, L" sort="Lacroix, L" uniqKey="Lacroix L" first="L" last="Lacroix">L. Lacroix</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003775 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003775 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:10026270
   |texte=   Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:10026270" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021